[Personalised medicine. Aims and challenges].

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
Read More Add to Saved list
  • Author(s): Bieber T;Bieber T; Broich K
  • Source:
    Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz [Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz] 2013 Nov; Vol. 56 (11), pp. 1468-72.
  • Publication Type:
    English Abstract; Journal Article
  • Language:
    German
  • Additional Information
    • Transliterated Title:
      Personalisierte Medizin. Zielsetzungen und Herausforderungen.
    • Source:
      Publisher: Springer Country of Publication: Germany NLM ID: 101181368 Publication Model: Print Cited Medium: Internet ISSN: 1437-1588 (Electronic) Linking ISSN: 14369990 NLM ISO Abbreviation: Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz Subsets: MEDLINE
    • Publication Information:
      Original Publication: Berlin : Springer,
    • Subject Terms:
      Biomarkers/*analysis ; Delivery of Health Care/*methods ; Delivery of Health Care/*trends ; Pharmacogenetics/*methods ; Pharmacogenetics/*trends ; Precision Medicine/*methods ; Precision Medicine/*trends
    • Abstract:
      Personalised medicine will address the clinical and pathophysiologic complexity of many diseases with the aim of developing therapeutic strategies more adapted for selected individuals or patient subgroups in order to improve efficacy and safety of medicinal products. This biomarker-based approach will potentially allow identification of populations at risk for chronic and life-threatening diseases and to design early intervention strategies. Personalised medicine will lead to a substantial move from costly and often inefficient health care to a hopefully more cost effective, more targeted and more preventive approach addressing participative patients with increased health literacy. Thus, it provides the basement for an ultimate paradigm shift of modern medicine, away from a "reactive" medicine to a more "proactive" and personalised health care, so-called "P4 medicine".
    • Accession Number:
      0 (Biomarkers)
    • Publication Date:
      Date Created: 20131031 Date Completed: 20140521 Latest Revision: 20160707
    • Publication Date:
      20231215
    • Accession Number:
      10.1007/s00103-013-1841-z
    • Accession Number:
      24170075